loading
Schlusskurs vom Vortag:
$3.25
Offen:
$3.22
24-Stunden-Volumen:
45,616
Relative Volume:
0.23
Marktkapitalisierung:
$38.82M
Einnahmen:
$12,000
Nettoeinkommen (Verlust:
$-48.41M
KGV:
-0.1889
EPS:
-17.181
Netto-Cashflow:
$-19.99M
1W Leistung:
-10.85%
1M Leistung:
+9.26%
6M Leistung:
-18.06%
1J Leistung:
-81.35%
1-Tages-Spanne:
Value
$3.22
$3.31
1-Wochen-Bereich:
Value
$3.1295
$3.615
52-Wochen-Spanne:
Value
$2.49
$20.31

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Firmenname
Incannex Healthcare Inc
Name
Telefon
61 409 840 786
Name
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
2026-10-05
Name
Neueste SEC-Einreichungen
Name
IXHL's Discussions on Twitter

Compare IXHL vs TAK, TEVA, HLN, ZTS, UTHR

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
IXHL icon
IXHL
Incannex Healthcare Inc
3.245 43.31M 12,000 -48.41M -19.99M -17.18
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.45 57.90B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
36.36 42.89B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.60 43.41B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
75.81 31.00B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
487.61 22.35B 3.17B 1.29B 1.01B 27.09

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

pulisher
Aug 20, 2026

IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits

Aug 20, 2026
pulisher
Aug 19, 2026

Incannex Healthcare (ASX:IHL) Cash Flow Check: What Investors Need to Watch on 19 August - Kalkine Media

Aug 19, 2026
pulisher
Aug 18, 2026

Why Is Incannex Healthcare (ASX:IHL) in Market Focus? - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

Why Did IXHL Stock Tank Over 32% Today? - Stocktwits

Aug 18, 2026
pulisher
Aug 17, 2026

Incannex Wins US Patent Lift For Sleep Apnoea Pipeline (ASX:IHL) - Kalkine Media

Aug 17, 2026
pulisher
Aug 15, 2026

Incannex Healthcare (IXHL) Climbs 3.8% to $3.28, Testing Key Resistance ZoneMcClellan Summation - vinanet.vn

Aug 15, 2026
pulisher
Aug 14, 2026

Polar Asset Management (IXHL) reports 7.0% beneficial stake via 900,000 warrants - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

$Incannex Healthcare (IXHL.US)$ - Moomoo

Aug 14, 2026
pulisher
Aug 14, 2026

Incannex (ASX:IHL): What Is Changing in the Liquidity Test? - Kalkine Media

Aug 14, 2026
pulisher
Aug 13, 2026

Why Does Incannex Healthcare (ASX:IHL) Shape Discipline? - Kalkine Media

Aug 13, 2026
pulisher
Aug 13, 2026

Incannex Healthcare (ASX:IHL) Clinical Development Pipeline: Market Outlook - Kalkine Media

Aug 13, 2026
pulisher
Aug 12, 2026

Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 12, 2026
pulisher
Aug 12, 2026

Incannex Healthcare Inc. (IXHL) options chain - Yahoo Finance Singapore

Aug 12, 2026
pulisher
Aug 12, 2026

Why Are Incannex Healthcare (ASX:IHL), Cann Group (ASX:CAN), ECS Botanics (ASX:ECS) and Little Green Pharma (ASX:LGP) Back in the Market Spotlight? - Kalkine Media

Aug 12, 2026
pulisher
Aug 12, 2026

Why Are BrainChip (ASX:BRN), Incannex Healthcare (ASX:IHL), Lake Resources (ASX:LKE) and Cann Group (ASX:CAN) Back in the Market Spotlight? - Kalkine Media

Aug 12, 2026
pulisher
Aug 11, 2026

Incannex receives final A$5.1m R&D tax incentive refund By Investing.com - Investing.com UK

Aug 11, 2026
pulisher
Aug 11, 2026

Incannex Healthcare Inc. (IXHL) stock price, news, quote and history - Yahoo Finance Singapore

Aug 11, 2026
pulisher
Aug 11, 2026

Incannex receives final A$5.1m R&D tax incentive refund - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - The Manila Times

Aug 11, 2026
pulisher
Aug 11, 2026

Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Nigeria

Aug 11, 2026
pulisher
Aug 11, 2026

Press Release: Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - Moomoo

Aug 11, 2026
pulisher
Aug 11, 2026

Incannex receives A$5.1M final R&D refund, totaling A$11.2M non-dilutive funding - TradingView

Aug 11, 2026
pulisher
Jul 30, 2026

Can Incannex (ASX:IHL) Reshape The Cannabis Conversation? - Kalkine Media

Jul 30, 2026
pulisher
Jul 28, 2026

Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

Incannex Healthcare Inc. (IXHL) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 27, 2026
pulisher
Jul 27, 2026

Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Incannex Healthcare Inc. Revenue Breakdown – NASDAQ:IXHL - TradingView

Jul 25, 2026
pulisher
Jul 25, 2026

IXHL|Incannex Healthcare Inc|Price:2.985|Chg%:+0.035 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Incannex Healthcare Inc (IXHL) Institutional Confidence - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Incannex Healthcare Inc (IXHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Incannex Healthcare Inc (IXHL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Incannex Healthcare Inc (IXHL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Incannex Healthcare Inc. Commences Participant Screening In Dreamzz Phase 2 Study Of IHL-42X For Obstructive Sleep Apnea - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

Incannex starts screening for Phase 2 study of IHL-42X to treat obstructive sleep apnea with FDA Fast Track status - Pluang

Jul 23, 2026
pulisher
Jul 23, 2026

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - The Manila Times

Jul 23, 2026
pulisher
Jul 23, 2026

Incannex Commences Screening in Phase 2 DReAMzz Study of IHL-42X for OSA - TradingView

Jul 23, 2026
pulisher
Jul 22, 2026

What Has Incannex (ASX:IHL) in Health Debate? - Kalkine Media

Jul 22, 2026
pulisher
Jul 22, 2026

Incannex Healthcare (IXHL) Slides Toward Support as Selling Pressure IntensifiesHigh Yield Stocks - vinanet.vn

Jul 22, 2026
pulisher
Jul 21, 2026

IXHL Q2 2026 Earnings: Massive EPS Miss Highlights Cash Burn as Clinical-Stage Biotech Reports No Revenue - vinanet.vn

Jul 21, 2026
pulisher
Jul 19, 2026

IXHL Q2 2026 Earnings: Significant EPS Miss Amid Operational ExpendituresGuidance vs Actual - vinanet.vn

Jul 19, 2026
pulisher
Jul 18, 2026

IXHL Q2 2026 Earnings: Substantial EPS Miss Reflects Near-Term ChallengesProfit Margin Analysis - vinanet.vn

Jul 18, 2026
pulisher
Jul 17, 2026

Incannex Healthcare (IXHL) Edges Higher: Technical Levels in Focus After Modest GainMarket Leader Picks - vinanet.vn

Jul 17, 2026
pulisher
Jul 16, 2026

Incannex Healthcare Secures US Patent Grant for Obstructive Sleep Apnea Treatment IHL-42XFinancial Health Score - Vinanet

Jul 16, 2026
pulisher
Jul 15, 2026

Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X - Sleep Review

Jul 15, 2026
pulisher
Jul 15, 2026

Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X - Yahoo Finance

Jul 15, 2026

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.10
price down icon 1.66%
RDY RDY
$11.97
price down icon 0.50%
$24.50
price up icon 0.33%
$155.64
price down icon 1.71%
$16.88
price down icon 0.35%
$487.61
price down icon 0.54%
Kapitalisierung:     |  Volumen (24h):